Issar Pharma Pvt. Ltd. was established in 1995 by Mr. Ramakrishna Reddy Isanaka with prime focus of research and development of New Chemical Entities (NCE) for various unmet medical needs.
India’s first ever peptide molecule for the treatment of Vitiligo was developed way back in 2004 and the second peptide New Chemical Entity (NCE) which is first ever peptide-based drug in the world to treat burn wounds and microbial infections.
